Potentially promising Alzheimer’s drug going forward

 In News

A drug created by the company Biogen might be able to slow the progression of Alzheimer’s Disease.

The company initially discontinued work on aducanumab when it started with disappointing results. They now say that a further analysis of that same data has actually suggested it may decrease cognitive loss in its treatment of Alzheimer’s Disease.

Dr. Andrew Frank speaks with Rob Snow on 580 CFRA

Dr. Andrew Frank of Bruyère spoke about it yesterday on CFRA. Dr. Frank suggests further trials will be necessary, but that this remains a positive development in the world of dementia.

Recent Posts
Showing 2 comments

Leave a Comment

Contact Us

Please send us an email with any of your questions and we'd be happy to get back to you.

Start typing and press Enter to search

Subscribe to The Monthly Bulletin

Delivered each month, The Monthly Bulletin provides information on the vital programs and services provided by The Dementia Society of Ottawa and Renfrew County. You may unsubscribe at any time with the link provided in every bulletin.